3,252 hedge funds and large institutions have $202B invested in Pfizer in 2022 Q4 according to their latest regulatory filings, with 342 funds opening new positions, 1,264 increasing their positions, 1,334 reducing their positions, and 101 closing their positions.

Holders
3,252
Holders Change
+182
Holders Change %
+5.93%
% of All Funds
52.48%
Holding in Top 10
193
Holding in Top 10 Change
+37
Holding in Top 10 Change %
+23.72%
% of All Funds
3.11%
New
342
Increased
1,264
Reduced
1,334
Closed
101
Calls
$3.09B
Puts
$2.77B
Net Calls
+$321M
Net Calls Change
-$337M
Name Market Value Shares Shares
Change
Shares
Change %
GC
3351
Gould Capital
Washington
-40 Closed
AWMS
3352
Advocacy Wealth Management Services
Georgia
-39 Closed
BWS
3353
BCR Wealth Strategies
Alabama
-25 Closed
APW
3354
Axim Planning & Wealth
Ohio
-5 Closed
LOAMU
3355
Lombard Odier Asset Management (USA)
New York
Parallax Volatility Advisers
3356
Parallax Volatility Advisers
California
LPARFS
3357
Leverage Partners Absolute Return Fund SPC
Cayman Islands
PMEF
3358
Point72 Middle East FZE
United Arab Emirates
WVP
3359
Worth Venture Partners
New Jersey
KGI
3360
Kopernik Global Investors
Florida
TA
3361
TCM Advisors
West Virginia
JGC
3362
J. Goldman & Co
New York
GCP
3363
Garda Capital Partners
Minnesota
HI
3364
HBK Investments
Texas
OIM
3365
Oracle Investment Management
Connecticut
SPM
3366
Symmetry Peak Management
Pennsylvania
PAG
3367
Paladin Advisory Group
Iowa
CM
3368
Caption Management
Oklahoma
CAM
3369
CenterStar Asset Management
Illinois
GPCM
3370
Granite Point Capital Management
Massachusetts
IMC Chicago
3371
IMC Chicago
Illinois
Walleye Capital
3372
Walleye Capital
New York
CCM
3373
Camber Capital Management
Massachusetts
MLIM
3374
Mountain Lake Investment Management
Florida
Twin Tree Management
3375
Twin Tree Management
Texas